HQH (abrdn Healthcare Investors) Beta: -0.1493 (As of Jun. 26, 2026)


HQH abrdn Healthcare Investors HQH
40 GF Score
Price $21.64
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors Beta?

abrdn Healthcare Investors HQH +1.98% 40 Beta is -0.1493 as of Jun. 26, 2026. GuruFocus rates HQH with a GF Score™ of 40/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), abrdn Healthcare Investors's Beta is -0.1493.


abrdn Healthcare Investors  (NYSE:HQH) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


abrdn Healthcare Investors Beta Related Terms


abrdn Healthcare Investors Beta Historical Data

* Premium members only.

The historical data trend for abrdn Healthcare Investors's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

abrdn Healthcare Investors Beta Chart

abrdn Healthcare Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Beta
Get a 7-Day Free Trial Premium Member Only 0.94 0.72 0.75 0.73 0.89

abrdn Healthcare Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.70 0.73 0.75 0.89 0.86

HQH vs FPF, AOD, CRF: Beta Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Healthcare Investors Beta vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Beta distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Beta falls into.


HQH
40GF Score
abrdn Healthcare Investors HQH
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

abrdn Healthcare Investors Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1493 mean?
abrdn Healthcare Investors (HQH) has a Beta of -0.1493 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for abrdn Healthcare Investors and its competitors.
Is abrdn Healthcare Investors' Beta too high?
abrdn Healthcare Investors' current Beta is -0.1493. Overall, abrdn Healthcare Investors has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' Beta compare to FPF and AOD?
abrdn Healthcare Investors' Beta of -0.1493 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Asset Management company?
A good Beta depends on the Asset Management industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for abrdn Healthcare Investors and its competitors. abrdn Healthcare Investors's current Beta is -0.1493. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.64 — trading 56.9% below its estimated fair value. The current Beta is -0.1493. abrdn Healthcare Investors' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current Beta is -0.1493 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $21.64 is trading 56.9% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • Beta: -0.1493
  • GF Value™: $50.26 vs. price of $21.64 (56.9% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
40GF Score

Get the complete analysis for HQH

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.64
Price
$50.26
GF Value